In AML, Ivey and colleagues (29), analyzed by ddPCR the kinetics of DNMT3A and IDH mutations in a large cohort of AML patients, who were in molecular remission for the NPM1-mutation. This evidence concerns the gene IDH1 and acute myeloid leukemia.